FDA Inspection
Lonza Walkersville, Inc.Lonza Walkersville, Inc. – FDA Inspection, Nov 5, 2021
Record Details
This FDA Inspection record concerns Lonza Walkersville, Inc., with an inspection on November 5, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Lonza Walkersville, Inc.
- Inspection Date
- November 5, 2021
- Product Type
- Biologics
View Company Profile
ID · ab81e874-10d0-4850-9abc-4c3daa579487
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1156019
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Lonza Walkersville, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 24, 2026 | NAI | Compliance: Devices | |
| July 26, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 3, 2018 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| February 6, 2017 | OAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 9, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Lonza Walkersville, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.